The TP53 genetic alterations have been demonstrated to exert an impact on the homeostasis of the TME in PDAC tissues, acting the gene as one of the principal modulators of disease progression by shaping the tumor-stromal environment [51]. This evidence concerns the gene TP53 and neoplasm.